Zhang G H, Baek L, Buchardt O, Koch C
Department of Immunology, State Serum Institute, Copenhagen, Denmark.
J Clin Microbiol. 1994 Jun;32(6):1537-41. doi: 10.1128/jcm.32.6.1537-1541.1994.
The coagulation of Limulus amebocyte lysate (LAL) can be activated through two pathways, one initiated by endotoxin and the other by beta-glucans. The two pathways join at the step of activation of the proclotting enzyme. We report here that the endotoxin-activated pathway can be differentially inhibited by two methods in a Limulus enzyme-linked immunosorbent assay (ELISA), either by the combined use of dimethyl sulfoxide and polymyxin B or by a monoclonal antibody against Limulus factor C. LAL reactivities to 10 different endotoxin preparations could be inhibited by the former method by a factor of 10(4) to 10(6) and could be blocked almost totally by the latter method, irrespective of the source of endotoxin. The sensitivity of the assay was approximately 50 pg/ml both for curdlan from Alcaligenes faecalis and for laminarin from Laminaria digitata. We also found that the beta-glucan-activated pathway could be totally blocked by laminarin (> 1 microgram/ml) without affecting the endotoxin-activated pathway, allowing endotoxin to be quantitated specifically by the Limulus ELISA with a detection limit of 0.005 endotoxin unit per ml. The use of uninhibited and differentially inhibited ELISAs demonstrated that different LAL preparations showed much greater variation in assaying beta-glucans than in assaying endotoxins. The LAL reactivity of normal human plasma was found to be due to the activation of the beta-glucan pathway, but not the endotoxin pathway, of LAL.
鲎试剂(LAL)的凝固可通过两条途径激活,一条由内毒素启动,另一条由β-葡聚糖启动。这两条途径在凝血酶原激活步骤汇合。我们在此报告,在内毒素激活途径中,鲎酶联免疫吸附测定(ELISA)可通过两种方法进行差异抑制,即二甲亚砜和多粘菌素B联合使用,或使用抗鲎因子C单克隆抗体。前一种方法可使LAL对10种不同内毒素制剂的反应性抑制10⁴至10⁶倍,后一种方法几乎可完全阻断,且与内毒素来源无关。该测定对粪产碱杆菌的短梗霉多糖和海带的昆布多糖的敏感性约为50 pg/ml。我们还发现,β-葡聚糖激活途径可被昆布多糖(>1μg/ml)完全阻断,而不影响内毒素激活途径,从而使鲎ELISA能够特异性定量内毒素,检测限为每毫升0.005内毒素单位。使用未抑制和差异抑制的ELISA表明,不同的LAL制剂在检测β-葡聚糖时比检测内毒素时表现出更大的差异。发现正常人血浆的LAL反应性是由于LAL的β-葡聚糖途径激活,而非内毒素途径激活。